tetano
Editor, Senior Moderator
Sci Rep
. 2024 May 28;14(1):12248.
doi: 10.1038/s41598-024-62541-x. Vaccination status and self-reported side effects after SARS-CoV-2 vaccination in relation to psychological and clinical variables in patients with multiple sclerosis
Katja Burian[SUP] 1 2 [/SUP], Felicita Heidler[SUP] 3 [/SUP], Niklas Frahm[SUP] 4 [/SUP], Michael Hecker[SUP] 4 [/SUP], Silvan Elias Langhorst[SUP] 4 [/SUP], Pegah Mashhadiakbar[SUP] 4 [/SUP], Barbara Streckenbach[SUP] 4 3 [/SUP], Julia Baldt[SUP] 4 3 [/SUP], Janina Meißner[SUP] 4 3 [/SUP], Jörg Richter[SUP] 3 5 6 [/SUP], Uwe Klaus Zettl[SUP] 4 [/SUP]
Affiliations
The recent SARS-CoV-2 pandemic and the vaccination campaign posed a challenge to patients with autoimmune disease, such as multiple sclerosis (MS). We aimed for investigating whether psychological/sociodemographic/clinical characteristics of MS patients are associated with SARS-CoV-2 vaccination status and self-reported vaccination side effects (SEs). We have asked patients with MS about their willingness to receive recommended standard vaccinations pre-pandemically since June 2019. Between 10/2021 and 01/2022, we surveyed 193 of these MS patients about their current SARS-CoV-2 vaccination status, their perception of vaccination-related SEs, and reasons for and against SARS-CoV-2 vaccination. 75.6% of the patients declared their willingness to receive standard vaccinations before the pandemic. 84.5%, 78.2%, and 13.0% of the patients had received the first, second, and third SARS-CoV-2 vaccination, respectively, until the follow-up survey. The most common reason for not getting vaccinated against SARS-CoV-2 was concern about possible side effects (82.1%), followed by the belief that the vaccines had not been adequately tested (64.3%). Vaccination-related SEs were reported by 52.8% of the patients. Younger age, higher education, lower degree of disability, relapsing disease course, shorter disease duration, not receiving a disease-modifying therapy and higher anxiety and depression levels were associated with the occurrence of certain vaccination-related SEs. Concerns about novel vaccines are widespread among MS patients and necessitate targeted education of the patients, especially to those with more severe psychopathological symptoms (anxiety or depression) and those who are generally skeptical of vaccination.
Keywords: Multiple sclerosis; SARS-CoV-2; Side effects; Vaccination hesitancy; Vaccination status; Vaccination willingness.
. 2024 May 28;14(1):12248.
doi: 10.1038/s41598-024-62541-x. Vaccination status and self-reported side effects after SARS-CoV-2 vaccination in relation to psychological and clinical variables in patients with multiple sclerosis
Katja Burian[SUP] 1 2 [/SUP], Felicita Heidler[SUP] 3 [/SUP], Niklas Frahm[SUP] 4 [/SUP], Michael Hecker[SUP] 4 [/SUP], Silvan Elias Langhorst[SUP] 4 [/SUP], Pegah Mashhadiakbar[SUP] 4 [/SUP], Barbara Streckenbach[SUP] 4 3 [/SUP], Julia Baldt[SUP] 4 3 [/SUP], Janina Meißner[SUP] 4 3 [/SUP], Jörg Richter[SUP] 3 5 6 [/SUP], Uwe Klaus Zettl[SUP] 4 [/SUP]
Affiliations
- PMID: 38806524
- PMCID: PMC11133397
- DOI: 10.1038/s41598-024-62541-x
The recent SARS-CoV-2 pandemic and the vaccination campaign posed a challenge to patients with autoimmune disease, such as multiple sclerosis (MS). We aimed for investigating whether psychological/sociodemographic/clinical characteristics of MS patients are associated with SARS-CoV-2 vaccination status and self-reported vaccination side effects (SEs). We have asked patients with MS about their willingness to receive recommended standard vaccinations pre-pandemically since June 2019. Between 10/2021 and 01/2022, we surveyed 193 of these MS patients about their current SARS-CoV-2 vaccination status, their perception of vaccination-related SEs, and reasons for and against SARS-CoV-2 vaccination. 75.6% of the patients declared their willingness to receive standard vaccinations before the pandemic. 84.5%, 78.2%, and 13.0% of the patients had received the first, second, and third SARS-CoV-2 vaccination, respectively, until the follow-up survey. The most common reason for not getting vaccinated against SARS-CoV-2 was concern about possible side effects (82.1%), followed by the belief that the vaccines had not been adequately tested (64.3%). Vaccination-related SEs were reported by 52.8% of the patients. Younger age, higher education, lower degree of disability, relapsing disease course, shorter disease duration, not receiving a disease-modifying therapy and higher anxiety and depression levels were associated with the occurrence of certain vaccination-related SEs. Concerns about novel vaccines are widespread among MS patients and necessitate targeted education of the patients, especially to those with more severe psychopathological symptoms (anxiety or depression) and those who are generally skeptical of vaccination.
Keywords: Multiple sclerosis; SARS-CoV-2; Side effects; Vaccination hesitancy; Vaccination status; Vaccination willingness.